Global Anti-Snoring Devices Market Grows at a Staggering CAGR of 8.04%

Introduction

The global market for anti-snoring devices is seeing significant expansion, propelled by the rising incidence of sleep disorders, especially obstructive sleep apnea (OSA), and heightened awareness of health hazards associated with snoring, including cardiovascular problems and sleep loss.  The increasing prevalence of obesity and an ageing demographic, coupled with technological improvements in non-invasive treatments such as mandibular advancement devices (MADs) and nasal dilators, propel market expansion.  Emerging trends, such as smart anti-snoring devices with sensors and artificial intelligence, are increasingly popular, improving user comfort and adherence.

North America leads thanks to its sophisticated healthcare infrastructure, while Asia-Pacific is the most rapidly expanding area, driven by increasing disposable incomes and healthcare investments.  The market encounters obstacles such as elevated gadget expenses and insufficient knowledge in low-income regions; yet, growth is bolstered by advancements and the accessibility of e-commerce.  Strategic alliances and product introductions by major stakeholders enhance growth, catering to the needs of millions impacted by snoring worldwide.

Market Dynamics

Rising incidence of obesity and sleep apnea drives market growth

The increasing incidence of obesity and obstructive sleep apnea (OSA) significantly propels the anti-snoring devices market.   Obstructive Sleep Apnea (OSA), a critical sleep problem, affects around 1 billion people, according to a 2024 study published in the Journal of Clinical Medicine, markedly increasing the likelihood of severe health issues like cardiovascular illnesses, hypertension, and stroke.  This significant health challenge amplifies the necessity for efficient non-invasive interventions such as mandibular advancement devices (MADs) and continuous positive airway pressure (CPAP) devices.

• For example, in May 2024, Glidewell announced the introduction of its entirely digital, 3D-printed Silent Nite® 3D Sleep Appliance, engineered for an accurate and comfortable fit to mitigate snoring and mild to moderate obstructive sleep apnea (OSA).  This announcement underscores the increasing demand for these oral appliances.

Awareness programs, exemplified by the National Sleep Foundation and advantageous reimbursement policies in North America, further promote adoption.  The increasing elderly population, with 25% of U.S. people snoring regularly, heightens the demand for effective anti-snoring remedies.

Technological innovations in customisable devices create tremendous opportunities

Technological breakthroughs in customisable anti-snoring devices offer substantial market prospects, propelled by innovations such as 3D printing and AI-driven personalisation.  These innovations improve device comfort and effectiveness, meeting consumers' desire for non-invasive alternatives.

• For example, in January 2024, SnoreLessNow introduced their FDA-cleared Anti-Snore Mouth Guard+, created in partnership with Oscimed SA, utilising 3D digital scanning to manufacture precisely customised oral devices.  This breakthrough markedly boosts airflow and substantially improves the management of obstructive sleep apnea (OSA), exemplifying the efficacy of precision manufacturing.
• Similarly, in April 2024, Smartee Dental Technology launched their unique S8 aligners, which effectively integrate mandibular advancement with conventional tooth alignment, providing a groundbreaking dual-purpose treatment for severe malocclusion.

These developments correspond with the increasing demand for home-based, user-friendly technologies, bolstered by rising disposable incomes in Asia-Pacific.  Government actions enhance access to modern technologies, facilitating market scalability and acceptance in highly prevalent areas.

Regional Analysis

North America dominates the anti-snoring devices market owing to its sophisticated healthcare infrastructure and extensive knowledge of sleep disorders.  The region benefits from substantial governmental and private investment in sleep research and innovation, and significant market companies are continually introducing technologically sophisticated solutions.  Consumer demand for non-invasive, home-based therapies is increasing, propelled by heightened health awareness and the adoption of telemedicine.  Favourable reimbursement regulations, public awareness initiatives, and enhanced healthcare accessibility promote the use of anti-snoring devices.  The prevalence of lifestyle-related disorders and an ageing population augment the demand for personalised and user-friendly sleep aids, reinforcing the region's market dominance.

Key Highlights

• The global anti-snoring devices market size was valued at USD 1.38 billion in 2024 and is projected to grow from USD 1.49 billion in 2025 to USD 2.74 billion in 2033, exhibiting a CAGR of 7.92% during the forecast period (2025-2033).
• By Product Type, the market is segmented into oral appliances, nasal devices, continuous positive airway pressure (CPAP) devices, chin straps, position control devices, smart anti-snoring devices, and others. Oral appliances, particularly mandibular advancement devices (MADs), dominate the anti-snoring devices market, holding a 38% revenue share in 2024.
• By Distribution Channel, the market is segmented into online retail, hospital pharmacies, retail pharmacies, clinics, and others. Online retail leads the distribution channel segment with a 42% share in 2024, driven by the ease of direct-to-consumer (DTC) shopping and a growing preference for e-commerce.
• By End User, the market is segmented into homecare, hospitals, sleep clinics, and others. The homecare segment dominates the end-user landscape, capturing 55% of the market in 2024, due to the increasing demand for non-invasive, self-managed snoring solutions.
• Based on region, the global market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominates the global market.

Competitive Players

1. ResMed
2. Koninklijke Philips N.V.
3. SomnoMed
4. Fisher & Paykel Healthcare
5. Glidewell
6. ZQuiet
7. SnoreLessNow
8. Apnea Sciences
9. VVFLY Electronics
10. Illusion Aligners
11. Airway Management
12. Theravent
13. Rhinomed
14. Smart Nora
15. DeVilbiss Healthcare
16. Others

Recent Developments

• In January 2025, SnoreLessNow expanded its FDA-cleared Anti-Snore Mouth Guard+ to Europe, leveraging 3D scanning for personalised MADs. This move targets Germany and France, capitalising on high OSA prevalence and e-commerce growth. The device’s comfort and efficacy strengthen SnoreLessNow’s position in the homecare segment, supporting market growth in tech-driven regions.
• In October 2024, Philips Respironics launched DreamMapper, a cloud-based platform enabling users to track sleep therapy data and connect with healthcare providers. This enhances compliance for CPAP and MAD users, addressing snoring and OSA. The platform’s integration with smart devices boosts Philips’ market presence in North America and Europe, aligning with the trend toward data-driven healthcare solutions.

Segmentation

1. By Product Type
   1. Oral Appliances
      1. Mandibular Advancement Devices (MADs)
      2. Tongue Stabilising Devices (TSDs)
   2. Nasal Devices
      1. Nasal Dilators
      2. Nasal Strips
   3. Continuous Positive Airway Pressure (CPAP) Devices
   4. Chin Straps
   5. Position Control Devices
   6. Smart Anti-Snoring Devices
   7. Others (e.g., Anti-Snoring Pillows)
2. By Distribution Channel
   1. Online Retail
   2. Hospital Pharmacies
   3. Retail Pharmacies
   4. Clinics
   5. Others (e.g., Speciality Stores)
3. By End User
   1. Homecare
   2. Hospitals
   3. Sleep Clinics
   4. Others (e.g., Research Institutes)
4. By Region
   1. North America
   2. Europe
   3. Asia-Pacific
   4. Latin America
   5. The Middle East and Africa